TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Teclison Ltd.
Teclison Ltd.
Iovance Biotherapeutics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca
Pfizer
Actuate Therapeutics Inc.
Merus B.V.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
Mirati Therapeutics Inc.
Pfizer
Boehringer Ingelheim
Pfizer
Integro Theranostics
Avistone Biotechnology Co., Ltd.
AstraZeneca
Gilead Sciences
AstraZeneca
AstraZeneca
AstraZeneca
Convalife (Shanghai) Co., Ltd.
Merck Sharp & Dohme LLC
Novartis
Regeneron Pharmaceuticals
Daiichi Sankyo
AstraZeneca
Boehringer Ingelheim
Pierre Fabre Medicament
Revolution Medicines, Inc.
Incyte Corporation
Jiangsu HengRui Medicine Co., Ltd.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Lantern Pharma Inc.
Tempus AI
AstraZeneca
BeiGene
Arcus Biosciences, Inc.
Incyte Corporation
Candel Therapeutics, Inc.
Sutro Biopharma, Inc.
Mirati Therapeutics Inc.
Apollomics Inc.
NanOlogy, LLC
Avistone Biotechnology Co., Ltd.
ImmunoGenesis
Teligene US
Faeth Therapeutics
Bristol-Myers Squibb
Alethia Biotherapeutics